Effectiveness and Safety of Dabigatran, Rivaroxaban, and Apixaban Versus Warfarin in Nonvalvular Atrial Fibrillation. uri icon

authors

  • Yao, Xiaoxi
  • Abraham, Neena S
  • Sangaralingham, Lindsey R
  • Bellolio, M Fernanda
  • McBane, Robert D
  • Shah, Nilay D
  • Noseworthy, Peter A

publication date

  • June 13, 2016